
As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator.
Loic Plantevin is a partner with Bain & Company, based in its Paris office. Christoph Schlegel is a partner in Bain’s Frankfurt office. Maria Gordian is a partner in its New York office.
As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator.
As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator, write Loic Plantevin, Christoph Schlegel and Maria Gordian.
Published: June 9th 2017 | Updated:
Published: July 1st 2017 | Updated: